Discovery and Development of a Novel mPGES-1/5-LOX Dual Inhibitor LFA-9 for Prevention and Treatment of Chronic Inflammatory Diseases
Nagendra Sastri Yarla,1 Gopal Pathuri,1,2 Hariprasad Gali,2 Simon Terzyan,3 Janani Panneerselvam,1 Parthasarathy Chandrakesan,4 Marcus Tullius Scotti,5 Courtney Houchen,4 Venkateshwar Madka,1 Chinthalapally V Rao1,6 1Center for Cancer Prevention and Drug Development, Hem-Onc Section, Department of M...
Saved in:
Main Authors: | Yarla NS (Author), Pathuri G (Author), Gali H (Author), Terzyan S (Author), Panneerselvam J (Author), Chandrakesan P (Author), Scotti MT (Author), Houchen C (Author), Madka V (Author), Rao CV (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary and Cardiorenal Cyclooxygenase-1 (COX-1), -2 (COX-2), and Microsomal Prostaglandin E Synthase-1 (mPGES-1) and -2 (mPGES-2) Expression in a Hypertension Model
by: Zaher A. Radi, et al.
Published: (2007) -
Role of COX-2/mPGES-1/Prostaglandin E2 Cascade in Kidney Injury
by: Zhanjun Jia, et al.
Published: (2015) -
CRISPR/Cas9-based liver-derived reporter cells for screening of mPGES-1 inhibitors
by: Zhanfei Chen, et al.
Published: (2019) -
Nitrooleic Acid Protects against Cisplatin Nephropathy: Role of COX-2/mPGES-1/PGE2 Cascade
by: Haiping Wang, et al.
Published: (2015) -
Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells
by: Filip Bergqvist, et al.
Published: (2019)